Kalyan Obalampalli
Founder and President, Clin.AI
Key Points
- Identifying problems through conversations is crucial
- Vendor selection is a complex process with many challenges
- Poor vendor choices can lead to significant financial losses
- Smaller companies face unique challenges in vendor management
- Utilising technology can streamline vendor selection
- The importance of financial oversight in clinical trials
Tom Lazenby and Kalyan Obalampalli discuss the challenges and opportunities in vendor management within clinical trials. Kalyan shares his journey in founding Clin.ai, a platform designed to streamline vendor selection and management processes. They explore the importance of networking, the lessons learned from previous experiences, and the critical role of financial oversight in clinical trials. The discussion also highlights the unique challenges faced by smaller biotech companies and offers practical tips for improving vendor selection processes.
Chapters
About the Guest
Kalyan Obalampalli
Founder and President, Clin.AI
Kalyan Obalampalli is a technology innovator with over 20 years of leadership experience in Clinical Operations and Outsourcing at major pharma and biotechs. Combining his expertise in clinical operations and software development, he has created user-friendly solutions, including a platform for clinical trial vendor selection and management.
With advisory experience in Silicon Valley start-ups, Kalyan brings a unique perspective to transforming Clinical Development Operations through technology.
Want to discuss vendor oversight?
Book a consultation with Tom Lazenby to explore how Mayet can support your clinical QA needs.